A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
Clinical trial NCT07354711 · RECRUITING
Trial details
- NCT number
- NCT07354711
- Sponsor
- 3H Pharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-04
- Primary completion
- 2028-01-01
- Enrollment
- 170
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.